Novo Nordisk announced its CagriSema GLP-1 weight loss drug underperformed Eli Lilly's tirzepatide in a trial. Separately, Lilly announced patients can use a single injector to hold a month's supply ...
Eli Lilly's success rate in clinical trials was phenomenal last year. The drugmaker has made a big name for itself in diabetes and weight loss. But it's also proving innovative even beyond its core ...
Eli Lilly is heading back to its regular Chinese collaborator Innovent Biologics with $350 million in upfront cash to collaborate on new meds for patients with cancer or immune disorders. The ...
With West End Girl, Lily Allen has reclaimed her pop throne while delivering record-breaking streams, a sold-out tour, and ...
Matthew Herper covers medical innovation — both its promise and its perils. Eli Lilly will pay up to $2.4 billion to acquire Orna Therapeutics, a biotechnology firm that is developing a technology to ...
Eli Lilly has struck a deal to buy genetic-medicine biotechnology company Orna Therapeutics for up to $2.4 billion in cash. Eli Lilly on Monday said Orna, which is dedicated to engineering immune ...
Based on Sam Wasson’s best-selling Fifth Avenue, 5 A.M.: Audrey Hepburn, Breakfast at Tiffany’s and the Dawn of the Modern Woman, which tells the behind-the-scenes story of the film’s production, the ...
Eli Lilly wants to export drugs made in India to markets across the world It has already committed to invest $1 billion in contract manufacturing in the country Also plans to bring other products to ...
In the pics, Heidi wears a hot pink lace bra and thong, while her brunette daughter sits by her side in a longline top and ...
Feb 9 (Reuters) - Eli Lilly will buy Orna Therapeutics for up to $2.4 billion in cash, gaining access to a technology that allows patients' own cells to generate therapies inside the body, without ...
SHANGHAI, Feb 9 (Reuters) - China's Innovent Biologics (1801.HK), opens new tab has struck a new deal with Eli Lilly (LLY.N), opens new tab to develop immunology and oncology drugs, under which the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results